June 21, 2022 — Marcus Schweiger, MDScientists known for their contributions to Cardiac PET imagingWas selected as the winner of this year George de Hevesy Nuclear Pioneer Award.. Schweiger Society of Nuclear Medicine and Molecular Imaging ((((SNMMI) At the 2022 annual meeting.
Schweiger is known for his important work in multimodal imaging for visualizing and quantifying biological processes. He played an important role in the advancement of nuclear heart disease, focusing on new quantitative methods and molecular mechanisms for developing radiotracers. His translational approach included both preclinical and clinical trials, resulting in the creation of a new diagnostic and image-guided therapeutic paradigm.Also includes Schweiger’s research interests Oncological PET, Similar to the diagnosis and treatment of thyroid endocrine and neuroendocrine disorders.
“Dr. Schweiger has proven to be a leader in scientific and clinical education and management throughout his career,” said SNMMI President. Richard L. Wall, MD, FACNM.. “From his job of establishing PET as a measure of myocardial viability, PET / MRI With imaging, training of a new generation of nuclear medicine leaders, and the establishment of an outstanding center at the Technische Universität München, his dedication to this area has significantly changed the way nuclear medicine and molecular imaging are practiced. “
Schweiger has completed medical research at the University of Freiburg in Germany and the Free University of Berlin. He completed his postdoctoral fellowship at the University of Cincinnati, Ohio and returned to Germany as a resident of the German Heart Center in Munich. From there, his career took him to the University of California, Los Angeles, where he used PET as a fellow and associate professor to provide new insights into the field of cardiology. In 1986, Schweiger moved to the University of Michigan, where he led the Cardiology and Cardiac PET program in Ann Arbor. Schweiger returned to Germany in 1993 and was the director of nuclear medicine at Klinikum rechtsder Isar at the Technische Universität München. In 2016 he became medical director and CEO of Klinikum rechts der Isar at Technische Universität München and retired in 2021.
“We are honored to receive the George de Hevesy Nuclear Medicine Pioneer Award from SNMMI,” Schweiger said. “At all stages of my career, I was able to work with highly talented colleagues who inspired and supported me. Together we are in the fields of nuclear medicine and molecular imaging. We have made progress. Now I am excited to observe and admire what the next generation of nuclear medicine researchers will discover. “
Each year, SNMMI awards individuals the George de Hevesy Nuclear Medicine Pioneer Award for their outstanding contributions to the field of nuclear medicine. De Hevesy was awarded the Nobel Prize in Chemistry in 1943 for his determination of the absorption, distribution, metabolism and removal of radioactive compounds in the human body. His work laid the foundation for nuclear medicine as a tool for diagnosis and treatment, and he is considered the father of nuclear medicine. SNMMI has been awarded the de Hevesy Award annually since 1960 to honor groundbreaking research in the field of nuclear medicine.
The list of previous winners of this award includes a number of Nobel laureates, including Ernest Lawrence, who produced the world’s first cyclotron for the production of radionuclides, and Glenn T. Seaborg, who discovered more than half a dozen new elements. It contains.
For more information: www.snmmi.org
http://www.itnonline.com/content/markus-schwaiger-md-receives-snmmi-georg-charles-de-hevesy-nuclear-pioneer-award Markus Schwaiger, MD, SNMMI Georg Charles de Hevesy Nuclear Pioneer Award